On Nov 12, 2025, AZTR reported earnings of -0.67 USD per share (EPS) for Q3 25, beating the estimate of -0.79 USD, resulting in a 15.24% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -14.64% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
What were Azitra Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Azitra Inc reported EPS of -$0.67, beating estimates by 15.24%, and revenue of $0.00, 0% as expectations.
How did the market react to Azitra Inc's Q3 2025 earnings?
The stock price moved down -14.64%, changed from $0.41 before the earnings release to $0.35 the day after.
When is Azitra Inc expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Azitra Inc's next earnings report?
Based on --
analysts, Azitra Inc is expected to report EPS of -- and revenue of -- for Q-- --.